COVID-19-associated acute kidney injury : consensus report of the 25th Acute Disease Quality Initiative (ADQI) Workgroup
- Author
- Mitra K. Nadim, Lui C. Forni, Ravindra L. Mehta, Michael J., Jr. Connor, Kathleen D. Liu, Marlies Ostermann, Thomas Rimmelé, Alexander Zarbock, Samira Bell, Azra Bihorac, Vincenzo Cantaluppi, Eric Hoste (UGent) , Faeq Husain-Syed, Michael J. Germain, Stuart L. Goldstein, Shruti Gupta, Michael Joannidis, Kianoush Kashani, Jay L. Koyner, Matthieu Legrand, Nuttha Lumlertgul, Sumit Mohan, Neesh Pannu, Zhiyong Peng, Xose L. Perez-Fernandez, Peter Pickkers, John Prowle, Thiago Reis, Nattachai Srisawat, Ashita Tolwani, Anitha Vijayan, Gianluca Villa, Li Yang, Claudio Ronco and John A. Kellum
- Organization
- Abstract
- Kidney involvement in patients with coronavirus disease 2019 (COVID-19) is common, and can range from the presence of proteinuria and haematuria to acute kidney injury (AKI) requiring renal replacement therapy (RRT; also known as kidney replacement therapy). COVID-19-associated AKI (COVID-19 AKI) is associated with high mortality and serves as an independent risk factor for all-cause in-hospital death in patients with COVID-19. The pathophysiology and mechanisms of AKI in patients with COVID-19 have not been fully elucidated and seem to be multifactorial, in keeping with the pathophysiology of AKI in other patients who are critically ill. Little is known about the prevention and management of COVID-19 AKI. The emergence of regional 'surges' in COVID-19 cases can limit hospital resources, including dialysis availability and supplies; thus, careful daily assessment of available resources is needed. In this Consensus Statement, the Acute Disease Quality Initiative provides recommendations for the diagnosis, prevention and management of COVID-19 AKI based on current literature. We also make recommendations for areas of future research, which are aimed at improving understanding of the underlying processes and improving outcomes for patients with COVID-19 AKI.
- Keywords
- RENAL-REPLACEMENT THERAPY, CRITICALLY-ILL PATIENTS, POLYMYXIN-B HEMOPERFUSION, SEPTIC SHOCK, BALANCED CRYSTALLOIDS, PERITONEAL-DIALYSIS, COVID-19, CORONAVIRUS, SARS-COV-2, INFECTION
Downloads
-
2020 Nadim COVID-19-associated acute kidney injury - consensus report of the 25th Acute Disease Quality Initiative Workgroep.pdf
- full text (Published version)
- |
- open access
- |
- |
- 1.90 MB
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-8681564
- MLA
- Nadim, Mitra K., et al. “COVID-19-Associated Acute Kidney Injury : Consensus Report of the 25th Acute Disease Quality Initiative (ADQI) Workgroup.” NATURE REVIEWS NEPHROLOGY, vol. 16, no. 12, 2020, pp. 747–64, doi:10.1038/s41581-020-00356-5.
- APA
- Nadim, M. K., Forni, L. C., Mehta, R. L., Connor, M. J., Jr., Liu, K. D., Ostermann, M., … Kellum, J. A. (2020). COVID-19-associated acute kidney injury : consensus report of the 25th Acute Disease Quality Initiative (ADQI) Workgroup. NATURE REVIEWS NEPHROLOGY, 16(12), 747–764. https://doi.org/10.1038/s41581-020-00356-5
- Chicago author-date
- Nadim, Mitra K., Lui C. Forni, Ravindra L. Mehta, Michael J. Connor Jr., Kathleen D. Liu, Marlies Ostermann, Thomas Rimmelé, et al. 2020. “COVID-19-Associated Acute Kidney Injury : Consensus Report of the 25th Acute Disease Quality Initiative (ADQI) Workgroup.” NATURE REVIEWS NEPHROLOGY 16 (12): 747–64. https://doi.org/10.1038/s41581-020-00356-5.
- Chicago author-date (all authors)
- Nadim, Mitra K., Lui C. Forni, Ravindra L. Mehta, Michael J. Connor Jr., Kathleen D. Liu, Marlies Ostermann, Thomas Rimmelé, Alexander Zarbock, Samira Bell, Azra Bihorac, Vincenzo Cantaluppi, Eric Hoste, Faeq Husain-Syed, Michael J. Germain, Stuart L. Goldstein, Shruti Gupta, Michael Joannidis, Kianoush Kashani, Jay L. Koyner, Matthieu Legrand, Nuttha Lumlertgul, Sumit Mohan, Neesh Pannu, Zhiyong Peng, Xose L. Perez-Fernandez, Peter Pickkers, John Prowle, Thiago Reis, Nattachai Srisawat, Ashita Tolwani, Anitha Vijayan, Gianluca Villa, Li Yang, Claudio Ronco, and John A. Kellum. 2020. “COVID-19-Associated Acute Kidney Injury : Consensus Report of the 25th Acute Disease Quality Initiative (ADQI) Workgroup.” NATURE REVIEWS NEPHROLOGY 16 (12): 747–764. doi:10.1038/s41581-020-00356-5.
- Vancouver
- 1.Nadim MK, Forni LC, Mehta RL, Connor MJ Jr, Liu KD, Ostermann M, et al. COVID-19-associated acute kidney injury : consensus report of the 25th Acute Disease Quality Initiative (ADQI) Workgroup. NATURE REVIEWS NEPHROLOGY. 2020;16(12):747–64.
- IEEE
- [1]M. K. Nadim et al., “COVID-19-associated acute kidney injury : consensus report of the 25th Acute Disease Quality Initiative (ADQI) Workgroup,” NATURE REVIEWS NEPHROLOGY, vol. 16, no. 12, pp. 747–764, 2020.
@article{8681564, abstract = {{Kidney involvement in patients with coronavirus disease 2019 (COVID-19) is common, and can range from the presence of proteinuria and haematuria to acute kidney injury (AKI) requiring renal replacement therapy (RRT; also known as kidney replacement therapy). COVID-19-associated AKI (COVID-19 AKI) is associated with high mortality and serves as an independent risk factor for all-cause in-hospital death in patients with COVID-19. The pathophysiology and mechanisms of AKI in patients with COVID-19 have not been fully elucidated and seem to be multifactorial, in keeping with the pathophysiology of AKI in other patients who are critically ill. Little is known about the prevention and management of COVID-19 AKI. The emergence of regional 'surges' in COVID-19 cases can limit hospital resources, including dialysis availability and supplies; thus, careful daily assessment of available resources is needed. In this Consensus Statement, the Acute Disease Quality Initiative provides recommendations for the diagnosis, prevention and management of COVID-19 AKI based on current literature. We also make recommendations for areas of future research, which are aimed at improving understanding of the underlying processes and improving outcomes for patients with COVID-19 AKI.}}, author = {{Nadim, Mitra K. and Forni, Lui C. and Mehta, Ravindra L. and Connor, Michael J., Jr. and Liu, Kathleen D. and Ostermann, Marlies and Rimmelé, Thomas and Zarbock, Alexander and Bell, Samira and Bihorac, Azra and Cantaluppi, Vincenzo and Hoste, Eric and Husain-Syed, Faeq and Germain, Michael J. and Goldstein, Stuart L. and Gupta, Shruti and Joannidis, Michael and Kashani, Kianoush and Koyner, Jay L. and Legrand, Matthieu and Lumlertgul, Nuttha and Mohan, Sumit and Pannu, Neesh and Peng, Zhiyong and Perez-Fernandez, Xose L. and Pickkers, Peter and Prowle, John and Reis, Thiago and Srisawat, Nattachai and Tolwani, Ashita and Vijayan, Anitha and Villa, Gianluca and Yang, Li and Ronco, Claudio and Kellum, John A.}}, issn = {{1759-5061}}, journal = {{NATURE REVIEWS NEPHROLOGY}}, keywords = {{RENAL-REPLACEMENT THERAPY,CRITICALLY-ILL PATIENTS,POLYMYXIN-B HEMOPERFUSION,SEPTIC SHOCK,BALANCED CRYSTALLOIDS,PERITONEAL-DIALYSIS,COVID-19,CORONAVIRUS,SARS-COV-2,INFECTION}}, language = {{eng}}, number = {{12}}, pages = {{747--764}}, title = {{COVID-19-associated acute kidney injury : consensus report of the 25th Acute Disease Quality Initiative (ADQI) Workgroup}}, url = {{http://doi.org/10.1038/s41581-020-00356-5}}, volume = {{16}}, year = {{2020}}, }
- Altmetric
- View in Altmetric
- Web of Science
- Times cited: